Efficacy and safety of pembrolizumab for patients with previously treated advanced vulvar squamous cell carcinoma: Results from the phase 2 KEYNOTE-158 study.
Sign Up to like & getrecommendations! Published in 2022 at "Gynecologic oncology"
DOI: 10.1016/j.ygyno.2022.01.029
Abstract: OBJECTIVE Treatment options for advanced vulvar cancer are limited. We evaluated pembrolizumab monotherapy in patients with advanced vulvar squamous cell carcinoma (SCC) enrolled in the phase 2 multicohort, open-label KEYNOTE-158 study (NCT02628067). METHODS Eligible patients… read more here.
Keywords: pembrolizumab; cell carcinoma; treatment; squamous cell ... See more keywords
443 High-dose density neoadjuvant chemotherapy before radical surgery in advanced vulvar cancer
Sign Up to like & getrecommendations! Published in 2019 at "International Journal of Gynecological Cancer"
DOI: 10.1136/ijgc-2019-igcs.443
Abstract: Objectives Mortality is high in advanced vulvar cancer and treatment associate with several adverse events. Neoadjuvant chemotherapy (NAC) administered before surgery is successful in patients with bulky squamous cervical cancer. We used NAC in 10… read more here.
Keywords: neoadjuvant chemotherapy; radical surgery; vulvar cancer; advanced vulvar ... See more keywords